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Articular cartilage maturation is the postnatal development process that adapts joint surfaces to their
site-speciﬁc biomechanical demands. Maturation involves gross morphological changes that occur
through a process of synchronised growth and resorption of cartilage and generally ends at sexual
maturity. The inability to induce maturation in biomaterial constructs designed for cartilage repair has
been cited as a major cause for their failure in producing persistent cell-based repair of joint lesions. The
combination of growth factors FGF2 and TGFb1 induces accelerated articular cartilage maturation in vitro
such that many molecular and morphological characteristics of tissue maturation are observable. We
hypothesised that experimental growth factor-induced maturation of immature cartilage would result in
a biophysical and biochemical composition consistent with a mature phenotype. Using native immature
and mature cartilage as reference, we observed that growth factor-treated immature cartilages displayed
increased nano-compressive stiffness, decreased surface adhesion, decreased water content, increased
collagen content and smoother surfaces, correlating with a convergence to the mature cartilage
phenotype. Furthermore, increased gene expression of surface structural protein collagen type I in
growth factor-treated explants compared to reference cartilages demonstrates that they are still in the
dynamic phase of the postnatal developmental transition. These data provide a basis for understanding
the regulation of postnatal maturation of articular cartilage and the application of growth factor-induced
maturation in vitro and in vivo in order to repair and regenerate cartilage defects.
Crown Copyright  2012 Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Repair and regeneration of articular cartilage defects presents
biologists and bioengineers with formidable challenges.
From the biological perspective, repair of adult cartilage is
complicated in that this tissue is avascular, has a low cell to volume
ratio and is rich in glycosaminoglycan containing proteoglycans
producing a high negative ﬁxed charge density [1]. These attributes
limit active or passive cellular migration to the lesion site and
characterise the poor intrinsic healing capacity of adult tissue [2].
Above a threshold defect diameter of 3e6 mm, cartilage lesions
rarely heal spontaneously leading to progressive cartilage degen-
eration [3,4]. This latter impasse has been resolved to some extent
through cell transplantation of culture expanded, autologousn).
of Life Sciences, College of
ea, SA2 8PP, UK.
evier Ltd. Open access under CC BY liarticular chondrocytes or mesenchymal stem cell populations into
chondral defects [5-8]. Further complications arise as transplanted
cells initially adopt an immature cartilage phenotype that appears
to be subject to phenotypic instability [9], resulting in the inap-
propriate production of ﬁbrocartilage or calciﬁed tissue, both of
which are to varying degrees deleterious to joint function [10,11].
From the viewpoint of a bioengineer, articular cartilage tissue
engineering presents unique problems, namely the growth and
maturation of implanted biomaterial constructs in an environment,
theknee,wherepeak forces canbe seven-times bodyweight [12] and
where the joint can undergo an average of 5000 loading cycles
during normal daily activities [13].Whilst generation of neocartilage
using autologous donor chondrocytes or stem cells seeded within
fabricated scaffolds does frequently result in hyaline-like cartilage
[14], there is no evidence to show that these tissues then form adult,
mature cartilage with the bulk and interface properties consistent
with the latter phenotype [15,16]. Hunziker (2009) has hypothesised
the deﬁciencies of chondrocyte transplantation and matrix-assistedcense.
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lesions is due to an inability to induce the formation of functionally
competent mature articular cartilage.
Neocartilage generated through tissue engineering has many
similarities with foetal and immature articular cartilage. Immature
cartilages are characterised by the relatively isotropic nature of
collagen ﬁbril structure and cellular organisation compared to adult
cartilage. Mature cartilage has a pseudo-stratiﬁed structure
composed of superﬁcial, mid, deep and calciﬁed zones [17,18] and
the chondrocytes within each zone have specialised functions that
homeostatically regulate bulk and/or interface properties [19,20].
In addition to a stratiﬁed structure, the arcade-like organisation of
collagen ﬁbrils and the subdivision of the extracellular matrix into
pericellular, territorial and inter-territorial zones in mature carti-
lage are also critical factors in its ability to support physiological
joint forces [21e23]. In terms of biochemical and biophysical
properties mature cartilage is generally less elastic, smoother in
appearance, has lower water content and higher collagen content
with respect to wet weight than immature cartilage [1,24].
The developmental transformation of immature cartilage to one
that is anisotropic in structure and adapted to site- and joint-
speciﬁc function occurs postnatally in mammals and is stimulated
by biochemical and biomechanical cues that, in the case of the
former, some parts of which may be developmentally regulated
[17,25]. Immature cartilage, therefore, serves as a transient template
upon which the diversity of form and function may be elaborated
[26]. The rate at which postnatal maturation of immature cartilage
proceeds, to the point where there is no signiﬁcant difference with
mature cartilage varies from species to species, and is approxi-
mately two months, ﬁve months and 10e18 years postpartum for
rabbit, horse and human cartilages, respectively [15,17,27]. The
extended time of maturation and gradual adaptation of human
joints to dynamic loading has clinical implications, in that intrinsic
and extrinsic mechanisms for cartilage repair have to recapitulate
this developmental transformation in order to generate durable
repair tissue, especially in joints subjected to constant dynamic
loading [15]. Therefore, understanding the mechanisms that regu-
late postnatalmaturation is a critical step in advancing strategies for
cell and biomaterial based therapies for cartilage repair. Insulin
growth factor (IGF), transforming growth factor beta (TGFb) and
ﬁbroblast growth factor (FGF) families of cytokines are known to
regulate chondrocyte metabolism [28]. The levels of TGFb1 and
TGFb2 rise postnally and that of IGF1 peaks at puberty indicating
possible roles in tissue maturation [29,30]. Whilst IGF1 induces
tissue growth and stimulation of proteoglycan deposition during
in vitro culture of immature articular cartilage explants, it causes
a reduction in tensile mechanical function, properties inconsistent
with tissue maturation [31]. Developmental studies of TGFb family
member levels in articular cartilage indicate that while TGFb1-3 are
expressed prior to zonal stratiﬁcation, following stratiﬁcation
TGFb2 and TGFb3 levels remain high whilst those of TGFb1 are
much lower [32]. However, studies of in vitro cultured immature
cartilage explants show exogenously added TGFb1 promotes tissue
homeostasis with no overall change in their size, composition or
biomechanical function [31]. FGF2 exerts opposing effects on
immature cartilage, promoting mitosis and anabolism at low
concentration (<30 ng/ml) but inhibiting the same processes at
higher (30e300 ng/ml) concentration [33]. Combinations of factors
such as FGF2 and TGFb1 have synergistic effects on chondrocytes,
repressing collagen type II gene expression [34], reducing the
doubling time of culture expanded human chondrocytes and
maintaining their phenotypic stability [35]. FGF2 and TGFb1 have
also been used in the tissue engineering context to dedifferentiate
chondrocytes in order to induce cellular proliferation prior to using
IGF1 to promote redifferentiation and growth [36].Recent work has shown the combination of FGF2 (100 ng/ml)
and TGFb1 (10 ng/ml) induce precocious postnatal developmental
maturation of immature articular cartilage in vitro [37]. The most
conspicuous change within growth factor-treated cartilage
explants is evidence of synchronised growth and resorption that
results in thinner cartilage, mirroring morphological changes that
occur during maturation in vivo [17,27]. Further evidence of
maturation following growth factor treatment in cartilage explants
are an increase in the ratio of mature to immature collagen cross-
linking and developmentally encoded changes in extracellular
distribution of proteins such as perlecan. We therefore hypoth-
esised that key biophysical and biochemical properties character-
istic of mature cartilage appear concomitantly with changes in
morphology. This study used native immature and mature articular
cartilage as references to determine if morphological trans-
formation of growth factor-treated immature cartilage equated to
biophysical and biochemical changes consistent with a transition to
the mature phenotype.
2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma (Poole, UK) unless stated. Mature
(over 18 month old) and immature (7-day-old) cartilage from bovine steers was
obtained from local abattoirs. The age range of the mature donors was between 18
and 28 months.
2.2. Articular cartilage explant culture
Articular cartilage explants were surgically removed under sterile conditions
from immature metacarpophalangeal joints. Full depth explants were excised using
a 6 mm diameter biopsy punches (Stiefel Laboratories Inc, NC, USA) from the medial
aspect of the medial condyle of individual joints. Explants were placed initially in
Dulbecco’s modiﬁed Eagles medium (DMEM; Invitrogen, Paisley, UK) and washed in
the same medium to remove blood and small particulates due to the presence of
a small amount of subchondral bone lining the basal aspect of cartilages. Explants
were then cultured for 21 days in serum-free culture medium; DMEM (high glucose,
4.4 g ml1), 100 mg ml1 ascorbate-2-phosphate, 50 mg ml1 gentamicin, 10 mM
HEPES pH 7.5 (Invitrogen) supplemented with 10 mg ml1 insulin, 5.5 mg ml1
transferrin, 6.7 ng ml1 selenium (ITS), with or without 100 ng ml1 FGF2 and
10 ng ml1 TGFb1 (Peprotech, London, UK). Explants cultures were placed in
a humidiﬁed 5% CO2 incubator kept at 37 C and culture medium was changed on
every third day.
2.3. Imaging of articular cartilage
Eight micron sections of formalin-ﬁxed cartilage samples that had previously
been processed for wax embedding were hydrated and stained with 1% aqueous
Safranin-O for 120 s and for 1 min in 1% haemotoxylin. For detection of birefringence
by polarised light microscopy sections were hydrated and pretreated with 1% w/v
bovine testicular hyaluronidase in Tris-buffered saline for 1 h at 37 C then stained
for 1 h in 0.1% Sirius red F3BA in saturated aqueous picric acid. Stained sections were
brieﬂy washed in 0.01N HCL, dehydrated, cleared and mounted in DPX mounting
medium (RA Lamb, UK). For transmission electron microscopy, samples were
prepared as previously described [37]. Sections were contrasted with uranyl acetate
and lead citrate and examined with a JEOL 1010 transmission electron microscope
equipped with a Gatan Orius SC1000 CCD camera.
2.4. Biochemical analyses
Explants were weighed wet, frozen, lyophilised, reweighed dry then assayed for
sulphated glycosaminoglycan (sGAG) and hydroxyproline content. sGAG content
was measured with the dimethylmethylene blue assay using explants that had been
incubated for 120min in papain digestion buffer, 20 mM sodium acetate pH 6.8, 1mM
EDTA, 2 mM dithiothreitol & 300 mg ml1 papain at 60 C [38]. Values of sGAG were
determined against standards of shark derived chondroitin sulphate. Hydroxypro-
line content was determined by assaying acid hydrolysates of papain digested
samples using the method of Creemers et al. (1997) [39].
2.5. AFM analysis
AFM experiments were carried out with a Nanowizard II (JPK Instruments,
Berlin, Germany) equipped with nano-positioning sensors in all three axis and
closed-loop feedback for precise, repeatable scanning and probe positioning with
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the elastic modulus of the cartilage material by using the AFM tip as a nanoindentor.
Explants were washed in Hank’s balanced salt solution for 5 min and then incubated
in serum-free tissue culture media (DMEM). The Petri dish was then loaded onto
a Nanowizard II Petri dish holder (JPK Instruments) platform and held at 37 C while
nanoindentation experiments were conducted. High aspect ratio etched silicon
probes, dNTP10, (Bruker) of radius 20 nm with spring constants of 0.32 Nm1 and
resonant frequency 40e75 kHz were employed. Each cantilever used in the study
was individually calibrated, calculating the sensitivity from a reference, hard force
curve taken from the Petri dish surface. The cantilever-speciﬁc spring constants
were calculated using the inbuilt thermal noise method of the Nanowizard instru-
ment. A maximum load force of 20 nN was found to be optimal and applied to the
surface in each recorded force curve. The cantilever approach and retraction velocity
was constant, set at 1.8 mm s1. The Poisson ratio was assumed to equal 0.5. Nano-
indentation force experiments were conducted capturing 100 indentation curves in
each scan area (10  10 mm) of the explant surface. These data represented the basis
for the estimation of a sample’s adhesive properties and Young’s modulus (E) using
Hertzian mechanics [40,41]. Manipulation of both the approach and retraction
curves yields different measurements which were related to cell micromechanical
properties and adhesion respectively. The material stiffness is the slope of the
unloading curve at the maximum penetration depth, and, the minimum of the
retraction curve is the force needed to overcome the adhesion between the sample
and the probe. The Hertz model describes the simple case of elastic deformation of
two perfectly homogeneous smooth bodies touching under load. The Hertz model
presumes the indented sample is extremely thick in comparison to the indentation
depth. This was the case here, where the indentation depth at a trigger force of
20 nN was always <10% of the cartilage thickness and thus below Bueckle’s
indentation depth limit [42].
2.6. Surface topography analysis
AFM was also employed to analysis the surface topography of cartilage samples.
Images of the surfaces were recorded using tapping mode with silicon tips. Coor-
dinates of the surfaces were acquired on a scan area of 25  25 mm and 256  256
points. Surface features such as asperity heights and their curvature radius were
calculated according to Prokopovich and Perni (2010) [43]. In brief, asperities are
located as points on the surface whose coordinates are higher than those
surrounding. The 2D proﬁle of the asperity is ﬁtted with a parabola and the
curvature radius of the asperity tip is calculated from the parabolic equation
parameters. The height and curvature radius of each asperity is determined and the
distribution determined at the end.
2.7. Friction testing
The frictional coefﬁcient of cartilage explants was assessed using a pin-on-plate
tribometer, with phosphate-buffered saline (PBS) as a lubricant. Six millimeter
diameter freshly isolated and cultured articular cartilage explants, were ﬁxed onto
a nylon housing using cyanoacrylate. PBS was applied evenly over the polished glass
surface, providing an average depth of approximately 1 mm. The tissue was then
preloaded at 0.1 MPa for 120 s prior to disc rotation to ensure consistent boundary
lubrication as described previously with Neu et al [44]. The sliding speed was then
ramped to 12 mm/s, before data was recorded for 15 s. Retrospective analysis to
compute the mean frictional coefﬁcient was then completed using MS Excel
(Microsoft, Redmond, WA, USA).
2.8. Immunoﬂuoresence analysis of cartilage
Cultured or freshly isolated articular cartilage explants were frozen in n-hexane
cooled in a bath of dry ice and ethanol. Tissues were then mounted in optimal
cutting temperature embedding medium (Thermo Scientiﬁc, Epsom, UK) and eight
micron sections cut using a Bright OTF500 cryostat (Bright Instrument Co. Ltd,
Huntingdon, UK). Sections were dried and stored in foil at 20 C until use. Tissue
sections were ringed with wax pen, washed in Tris-buffered saline including 0.1%
Tween-20 (TBS/T) and then blocked in 10% goat serum for 30 min. Primary mono-
clonal antibody anti-human collagen type I (SigmaeAldrich, Poole, UK) was diluted
1:1000 in TBS/T then placed on sections and incubated overnight at 4 C. Sections
were washed three times in TBS/T then incubated with a 1:100 dilution of goat anti-
mouse FITC conjugated secondary antibodies for 1 h at room temperature. Sections
were washed repeatedly in TBS/T then coverslipped following the application of an
anti-bleaching reagent, Vectashield (Vectorlabs, Peterborough, UK), containing
propidium iodide as a nuclear marker.
2.9. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
Cultured or freshly isolated articular cartilage explants were frozen in n-hexane
as described above and stored at 70 C prior to RNA extraction. Frozen explants
were homogenised in the presence of frozen 0.5 ml TRI reagent using a mikro-
dismembrator U and chilled steel vessels (B. Braun Biotech International, Melsun-
gen, Germany). The supernantant from the latter process was placed in an RNAEasycolumn for total RNA extraction with DNAseI digestion step (Qiagen, Crawley, UK).
Total RNA was quantiﬁed using NanoDrop 2000 spectrophotometer (NanoDrop,
Wilmington, USA). One microgram of total RNA was used for reverse transcription
reaction using the GoScript kit utilizing M-MLV reverse transcriptase and random
primers (Promega, Southampton, UK). QPCR reactions were performed using the
GoTaq qPCR mastermix (Promega), 12.5 ng cDNA and 0.3 mM forward and reverse
primers. Reactions were performed on a Stratagene Mx3000 real-time PCR analyser
(Agilent Technologies, Edinburgh, UK) with the following thermal cycling program;
95 C for 10min1 cycle, 95 C 30 s, 55 C 60 s, 72 C 30 se40 cycles. Standard curves
over the linear range of ampliﬁcation were generated for all primer sets, and data
was used where the efﬁciency of ampliﬁcation was between 90% and 105% and the
melt curves generated a single product. The data shown is the ratio of the concen-
tration of the gene of interest (in nanogrammes) and 18S rRNA (in nanograms). The
nucleotide sequences of primer sets used in this studywere as follows; collagen type
IaI forward 50 TAC GCCCCA CCA GTC ACC TGC GTA C 30 reverse 50 GTT TCC ACA CGT
CTC GGT CA 30 , RSP18F 50 CAC TGG AGG CCT ACA CGC CG 30 and RSP18B 50 AGG CAA
TTT TCC GCC GCC CA 30 .
2.10. Statistical analysis
PASW18 (IBM, NY, USA) was used to statistically analyse these data. All datasets
were checked for normal distribution using the ShapiroeWilk test and homogeneity
of variances using Levene’s test prior to statistical analysis. For parametric analysis of
2 groups we used two-tailed Student’s paired sample t-test, and for multiple groups
a one-way analysis of variance test (ANOVA). The Bonferroni correction factor was
applied to avoid false positive results due to multiple testing. Where data was either
not normally distributed or variances not equal non-parametric Kruksal-Wallis and
ManneWhitney U tests were used for multiple and paired groups, respectively. The
sample size, N, of each study represents explants excised from individual donor
animals.
3. Results
3.1. Growth factor-induced postnal maturation of cartilage
In vitro culture of articular cartilage explants excised from imma-
ture metacarpophalangeal joints in the presence of FGF2
(100 ngml1) and TGFb1 (10 ngml1) for 21 days results in profound
morphological change [37]. This change is illustrated by tissue
resorption from the deep zone resulting in a reduction in height of
approximately 50%of growth factor-treated explantswhen compared
to paired control explants excised from directly adjacent sites of
the same joint and cultured in serum-free medium alone
(272.5  37.8 mm vs 143.5  33.7 mm, respectively, P < 0.001, N ¼ 4)
Fig. 1AeB. When viewed under polarising conditions by light
microscopy, we observed changes in the pattern of birefringence
surrounding individual chondrocytes in the surface zone of growth
factor-treated explantswhen compared to control untreated explants
where the birefringence signal was weaker and parallel to the
immediate surface, Fig. 1CeD. An increase in birefringence occurs as
a result of enhanced alignment or bundling of collagen ﬁbrils [45].
High resolution imaging of surface chondrocytes using transmission
electron microscopy revealed that surface zone chondrocytes in
growth factor-treated cartilage, corresponding to those cells display-
ing high birefringence, possessed a pericellular envelope enclosing
a proteoglycan rich glycocalyx. In comparison, surface chondrocytes
of explants cultured in control, serum-free medium were not sepa-
rated from the territorial matrix by a pericellular coat, Fig. 1DeE.
3.2. Biochemical analyses of in vitro maturation
Biochemical analyses of native and cultured articular cartilage
explants demonstrated that growth factor-treated cartilage was
signiﬁcantly different to both immature and serum-free cultured
immature cartilage explants inwater content (P < 0.05, N ¼ 6), dry/
wet weight ratio (P < 0.05, N ¼ 6) and hydroxyproline content
(P < 0.05, N ¼ 6), Table 1. There was no statistical difference in the
latter values when growth factor-treated cartilagewas compared to
native mature cartilage. There was no statistical difference in sGAG
values within native or cultured explant sample groups.
Fig. 1. FGF2 and TGFb1 induce potent morphological changes in immature articular cartilage during in vitro culture. Explants were taken from adjacent sites from the same
joint and cultured either in the absence (A) or continual presence (B) of 100 ng ml1 FGF2 and 10 ng ml1 TGFb1 for 21 days in ITS containing serum-free medium. Growth factor-
treated explants undergo signiﬁcant resorption resulting in the disappearance of hypertrophic chondrocytes that reside in the deep zone of immature articular cartilage (bracketed
in (A)]. Bar equals 500 mm. Polarising light microscopy of picro-sirius red stained sections of untreated (C) and growth factor-treated cartilage explants (D). The surface cartilage of
growth factor treated cartilage displays extensive changes in collagen orientation many ﬁbrils are anti-parallel to the surface axis (D). Also, a thin ﬂuorescent line parallel to the
surface (white arrows) delineates the lamina splendens, a collagen and lipid rich structure that is approximately 3 microns deep. This structure is absent in growth factor-treated
cartilage. Bar equals 50 mm. Electron microscopy of surface chondrocytes (7500) in untreated (E) and growth factor-treated (F) cartilage explants. Note the appearance of
a thickened pericellular coat surrounding individual surface chondrocytes in growth factor-treated cartilage (black arrow in F) compared to untreated cartilage where this micro-
anatomical unit of mature chondrocytes is absent (arrow in E). Also noteworthy is the increased collagen ﬁbril density in growth factor-treated cartilage explants (F). (For inter-
pretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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One key property of maturing cartilage is a progressive increase
in material stiffness [46]. Measuring the nanoscale compressive
strength of cartilage using AFM we observed freshly isolated
mature articular cartilage showed an increase in the median
values for Youngs’s modulus (Eind), and therefore a strengthening
or hardening of the apical surface compared to immature cartilage
(13.28 kPa interquartile range 2.81e35.34 versus 4.658 kPainterquartile range 3.199e7.582, respectively, P < 0.02, N ¼ 6),
Fig. 2AeB. We also observed an increase in median nano-
compressive stiffness between immature cartilage explants that
had been cultured for 21 days with growth factors FGF2 and TGFb1
compared to explants cultured in serum-free medium (97.8 kPa
interquartile range 4.82e244.4 versus 25.22 kPa interquartile
range 3.41e49.60, respectively, P < 0.02, N ¼ 6). The elastic moduli
values obtained for the treated samples were more variable than
the untreated cartilage and that of the mature cartilage controls.
Table 1
Comparison of biochemical composition measurements of freshly isolated imma-
ture and mature cartilage, and, in vitro cultured (ITS) and growth factor-treated (ITS-
FGF2-TGFb1) immature articular cartilages.
Immature AC Mature AC Immature AC
ITS ITS-FGF2-TGFb1
% water (mg)/wet
weight (mg)
73.8  1.07 68.7  1.67a 77.7  1.70 68.7  2.54b,a
dry/wet
weight ratio
0.26  0.01 0.31  0.02a 0.22  0.02 0.31  0.01b,a
hydroxyporoline
mg ml1
6.65  1.02 9.83  2.07nsd 5.63  0.93 8.30  0.88b
sGAG mg ml1 54.2  3.87 49.6  9.36nsd 38.2  7.96 42.7  6.79nsd
nsd, no signiﬁcant difference to control groups.
(N ¼ 6 for all groups, P < 0.05).
a Signiﬁcantly different from Immature AC.
b Signiﬁcantly different from serum-free cultured (ITS) immature cartilage.
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higher maximal adhesion forces than mature cartilage (1.67 nN
interquartile range 0.74e3.43 versus 0.84 nN interquartile range
0.10e2.72, P < 0.02, N ¼ 6, respectively) and this trend was also
replicated when maximal adhesive forces of unstimulated imma-
ture cartilage explants were compared to growth factor-treated
immature cartilage (1.32 nN interquartile range versus 0.98 nN
interquartile range 0.68e1.58, P < 0.02, N ¼ 6, respectively),
Fig. 2C.3.4. Surface topography
Examples of the surface topography examined using AFM are
shown in Fig. 3. It is evident that native mature cartilage is
smoother than immature cartilage, similarly samples treated with
growth factors appear smoother than control. Quantitative
assessment of the surface roughness through the values of Root
Mean Square (RRMS), deﬁned as the standard deviation of the
asperity heights, is presented in Table 2. These results conﬁrm that
following in vivo maturation cartilage become smoother (P < 0.05,
N¼ 6) as RRMS decreases; also the addition of growth factors results
in a lower values of surface roughness than the control samples
(P < 0.05, N ¼ 6). Furthermore, there was no difference in RRMS
values between mature cartilage and growth factor-treated carti-
lage explants (P > 0.05, N ¼ 6), indicating as previously demon-
strated for biochemical data a convergence in biophysical
properties.
Each asperity, beside its height, is deﬁned by the curvature
radius of the extremity. The distributions of such curvature radii, for
each of the samples, did not follow a Gaussian proﬁle (data not
shown); for this reason percentile values are presented instead of
mean and standard deviation in Table 2. Curvature radii of native or
growth factor-induced mature cartilages are greater than those of
control or native immature cartilages.3.5. Friction analysis of cartilage
The mean equilibrium frictional coefﬁcient of freshly isolated
mature cartilage was signiﬁcantly higher (4.6-fold) than its
immature counterpart (P < 0.01, N ¼ 4), Fig. 4. Similarly, the fric-
tional coefﬁcient of growth factor stimulated cartilage explants
were also 1.6-fold higher than explants cultured in medium lacking
growth factor (P < 0.014, N ¼ 5). Experimentally induced in vitro
maturation caused an approximately 3-fold rise in friction coefﬁ-
cient (P < 0.02, N ¼ 4) compared to freshly isolated immature
cartilage.3.6. Collagen gene expression in cartilage
Having observed changes in the biomechanical and frictional
properties at the apical interface of cartilages examined in this
study we investigated whether these differences correlated with
the presence of the surface structural protein, collagen type I. Using
ﬂuorescence microscopy we observed a contraction of, and, weaker
antibody labelling for collagen type I in the progression from native
immature to mature cartilage, Fig. 5A. A relatively thinner,
consolidated band of labelling was also evident in in vitro cultured
control cartilage explants compared to native immature cartilage,
and this band was noticeably more intense in growth factor stim-
ulated immature cartilages Fig. 5A. Using qPCR analysis, we
observed that collagen type Ia1 gene expression decreased 3.5-fold
in native mature cartilage compared to its immature counterpart
(P < 0.05, N ¼ 4). However, collagen type Ia1 expression levels rose
6.3-fold in growth factor stimulated cartilage explants compared to
cartilage explants cultured in control serum-free medium (P< 0.02,
N ¼ 4), Fig. 5B, indicating active remodelling of the surface zone.
4. Discussion
One of the major impediments in designing and implementing
cartilage repair procedures using cellular and biomaterial
composites has been the inability to induce and/or accelerate
maturation in vitro or in vivo. Immature articular cartilage is the
template upon which biomechanical and biochemical cues act in
adapting the tissue to joint-speciﬁc function through induction of
morphological, structural and biomolecular heterogeneity [26].
Data from equine studies, has shown that structural and
biochemical heterogeneity of joint cartilage is delayed upon exer-
cise deprivation in immature animals [47]. In the latter study,
Brama et al. (2002) also demonstrated that access to exercise after
deprivation signiﬁcantly delayed the appearance of tissue hetero-
geneity, and, in some collagen-related parameters was incomplete.
Therefore, articular cartilage maturation is partly a developmen-
tally encoded process, and is not recapitulated fully in moremature
animals through biomechanical conditioning alone. These latter
studies are of great signiﬁcance because the cellular components of
biomaterials composites are principally embryonic or adult
mesenchymal stem cells that produce immature neocartilage when
induced to differentiate. They also provide a rational basis to
explain why, in part, matrix-assisted repair strategies frequently do
not lead to healing of cartilage lesions and what is required to
overcome such obstacles.
Previous work has shown that in vitro culture of immature
articular cartilage in the presence of FGF2 and TGFb1 growth factors
induces morphological changes that are consistent with the post-
natal developmental transition to tissue maturity [17,37]. These
changes included a reduction in cartilage height of 50% through
resorption of the deep/epiphyseal-derived zone directed by co-
ordinated expression of matrix metalloproteinases 1, 13, 2
and 9, and, tissue inhibitor of metalloproteinases 1e3 [37]. The
decrease in height and the loss of hypertrophic chondrocytes
correlates with observations in studies of postnatal maturation in
the patellofemoral joints of mice and rabbits [17,48]. Resorption in
the deep zone of growth factor-treated explants is balanced by
growth from the surface zone driven by chondroprogenitor stem
cells. Our current data provides quantitative evidence that in vitro
growth factor-induced differentiation of immature articular carti-
lage results in biophysical and biochemical properties that are
indistinguishable from native mature cartilage.
The mean percentage water content and dry to wet weight ratio
of growth factor-treated cartilage explants were identical to values
obtained for native mature cartilages. As articular cartilage matures
Fig. 2. Changes in nanoscale elasticity and adhesive properties at the apical surface of articular cartilage. Representative loadedisplacement curves for nanoindendation
analysis of cartilage samples (A). Despite having heterogeneous surfaces [48,52], freshly isolated immature cartilage explants exhibited signiﬁcantly different ranges of both
elasticity (B) and adhesion (D) when compared to their mature tissue sample counterparts. These differences are visualised in the boxplot representation and were shown to be
signiﬁcant through ManneWhitney statistical analysis; P < 0.05. Similar results were observed for elasticity and adhesion measurements for immature growth factor-treated
cartilage explants and their untreated controls (C, E). A signiﬁcant (P < 0.05) increase in sample Young’s modulus, and therefore, stiffening of the surface was observed
following growth factor treatment when compared to the untreated control samples (C). A decrease in the adhesive status of the surface of growth factor-treated cartilage was
observed compared to the control samples, a signiﬁcant lowering of the 50% interquartile range is depicted in the boxplot analysis, indicating a reduction in the maximum force
needed to withdraw the AFM stylus from the sample surface (E). This behavioural characteristic was reversed when analysing the approach curves and sample elasticity of cartilages
where we observed an increase in the 50% interquartile range (B, C).
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extended culture in vitro, in free swelling conditions, the water
content of immature cartilage increases, however growth factor-
treated explants not only resisted accumulation of water duringculture but the water content values converged to those found in
native mature explants and were signiﬁcantly less than mean value
for native immature cartilage. [46]. Also, as articular cartilage
maturation proceeds, the dry to wet weight ratio of tissue
Fig. 3. AFM surface scan of freshly isolated immature and mature, and, serum-free (ITS) and growth factor-treated (ITS-FGF2-TGFb1) cultured articular cartilages. Roughness
analysis (see Table 2) revealed that mature cartilages and samples treated with growth factors were smoother than immature cartilages or control samples. In addition, we also note
that in surface scans, mature and growth factor-treated (ITS-FGF2-TGFb1) cartilage appeared more ﬁbrous and exhibit a less dimpled appearance than immature or cultured
immature (ITS) cartilages.
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cartilage had identical dry to wet weight ratios to mature cartilage,
correlating with a signiﬁcant increase in hydroxyproline (collagen)
content in this experimental group. There was no difference in
sGAG (proteoglycan) content between native immature and
mature, or, control and growth factor-treated cartilages and this
pattern of data is similar to that described by Williamson et al.
(2003) who observed no signiﬁcant difference in the sGAG content
between calf and young adult articular cartilage from the patellar-
femoral groove [49].
In the latter study (Williamson et al., 2003), measurements of
dynamic modulus showed a positive correlation (r2 ¼ 0.42,
P < 0.01) with collagen content. We used AFM to measure the
nanoscale biomechanical properties of cartilages, where we
observed that both growth factor-treated and mature cartilages
were signiﬁcantly less elastic than control and immature cartilages,Table 2
Surface roughness analysis using AFM of freshly isolated immature and mature, and,
immature cartilage explants cultured either in serum-free medium (ITS) or with
growth factors (ITS-FGF2-TGFb1).
Immature AC Mature AC Immature AC
ITS ITS-FGF2-TGFb1
RMS (mm) 0.83  0.15 0.49  0.10 0.79  0.12 0.55  0.09a,b
25th percentile
asperity radii (mm)
2.04 3.12 2.29 3.02
50th percentile
asperity radii (mm)
3.04 4.58 2.72 4.62
75th percentile
asperity radii (mm)
4.90 9.03 4.27 8.77
(N ¼ 6 for all groups, P < 0.05)
a Signiﬁcantly different from serum-free cultured (ITS) immature cartilage.
b Signiﬁcantly different from Immature AC.respectively. For this study we used nanometre-sized AFM tips that
have been shown previously by Stolz et al. (2009) to distinguish
differences in nano-compressive stiffness of articular cartilage from
femoral heads as a function of aging [48]. We observed that the
experimental stiffness values for cultured explants were signiﬁ-
cantly higher than those for freshly obtained tissue. The latter
increase was due to a reduction in glycosaminoglycan content in
in vitro cultured explants compared to freshly isolated native
cartilages that had the general effect of raising the observed stiff-
ness of these samples, also noted by Stolz et al. (2009) as
a phenomenon occurring in human cartilage during aging. There
was no signiﬁcant difference in sGAG values between native, or,
cultured explants, therefore negating proteoglycan content as
a factor for increases in nano-compressive stiffness within the
experimental group. The nanoscale data is determined by the
sharpness and shape of the cantilevered probe. The conical probes
used in this study were 20 nm in diameter and therefore are
interrogating the surface at the same scale as proteoglycans and
collagen ﬁbrils, which form the structural components of the
extracellular matrix. It is hypothesised that differences in surface
stiffness during cartilage maturation measured at the nanometer
scale represent changes in collagen structure, particularly in the
thickness or density of ﬁbres that can be modulated by ﬁbril
associated proteoglycans such as biglycan or decorin [50e52].
We also observed a similar pattern of results in nanoscale
adhesion properties, where growth factor-treated and native
mature cartilages exhibited reduced adhesion compared to
untreated and native immature cartilages. These data led us to
investigate the surface topography of cartilages, where we discov-
ered that surface roughness declines approximately 40% between
freshly obtained immature and mature cartilage, and 31% between
control and growth factor-treated cartilage. The RRMS values for
Fig. 5. Collagen type I expression during in vivo and in vitro articular cartilage developmental maturation. In freshly isolated tissue, labelling for anti-collagen type I antibodies
was observed as a broad and diffuse surface layer, and, localised as a thinner layer at the surface in mature cartilage (A). Labelling in cartilage explants cultured in serum-free (ITS) or
growth factor medium (ITS-FGF2-TGFb1) was more intense and was consolidated at the surface of these cartilages. Bar equals 50 mm. The ratio of collagen type IaI (in nanograms)
normalised to 18S rRNA (in nanograms) is shown (B). Transcript levels of collagen type IaI decrease approximately 3-fold (P < 0.05) as cartilage matures, but following in vitro
experimental maturation transcript levels increase approximately 6-fold compared to serum-free cultured (ITS) cartilage explants (P < 0.02).
Fig. 4. Biotribological analysis of articular cartilage explants. The coefﬁcient of friction (CoF) was measured for freshly isolated immature (7-day-old) and mature (>18 month
old) cartilages, and, in vitro cultured growth factor-treated and untreated immature cartilages (see Materials and Methods). The CoF of freshly isolated mature cartilages was
signiﬁcantly higher than their immature counterparts (P < 0.01). The CoF of growth factor-treated explants (ITS-FGF2-TGFb1) was also signiﬁcantly higher than untreated (ITS)
explants (P < 0.01). The CoF of growth factor-treated cartilage explants increased approximately 3-fold (P < 0.05) following in vitro culture for 21 days compared to freshly isolated
immature tissue.
I.M. Khan et al. / Biomaterials 34 (2013) 1478e1487 1485
I.M. Khan et al. / Biomaterials 34 (2013) 1478e14871486native mature and growth factor-treated immature cartilage were
not signiﬁcantly different again indicating a convergence of
biophysical properties to ones that characterise mature articular
cartilage. Furthermore, the radii of asperities increased in mature
and growth factor-treated cartilages by approximately the same
magnitude. These data suggest as cartilage matures, the surface
becomes stiffer and exhibits smoothing that results in a reduction
of surface adhesion properties. These results conﬁrm the ﬁndings of
Ghadially et al. (1978) who observed by scanning electron micros-
copy ‘innumerable humps’ in immature articular cartilage from
feline femoral condyles that in more mature cartilagewere reduced
in number and height, thus, revealing a comparatively smoother
but more wrinkled surface [53]. Hump-like features were also
present in native and cultured immature cartilages, but their
appearance was reduced in native mature and in vitro matured
cartilage.
The equilibrium frictional coefﬁcient of native mature articular
cartilage was greater than that of corresponding immature tissue,
and, growth factor-treated cartilage greater than native and
cultured control immature cartilages. The magnitude of friction is
potentially inﬂuenced by factors including the surface roughness,
stiffness and ﬂuid pressurisation (liable to vary with cartilage
thickness). The reduction in asperity height (i.e. roughness) would,
in isolation, be expected to correlate with mature cartilage
demonstrating a decreased frictional coefﬁcient. That the frictional
coefﬁcient increases during growth factor-induced maturation
suggests that a concomitant increase in stiffness reduces the tissue
deformation to such an extent that a greater (frictional) force is
required to slide one surface over the other. This reasoning may
explain, in part, why loss of PRG4 (lubricin) expression in a mouse
knockout model leads to precocious wear only in mature joints
[51]. The cartilage thickness could have also inﬂuenced the lubri-
cation and thereby the extent of friction, through the generation of
differential ﬂuid pressures (i.e. a greater thickness has the potential
to generate higher ﬂuid pressure, thereby enhanced lubrication and
a lower frictional coefﬁcient). Whilst the relatively thick (mature
and growth factor-treated) cartilages do indeed exhibit lower fric-
tional coefﬁcients, the potential inﬂuence of variable ﬂuid pres-
surisation was controlled by the application of a 0.1 MPa pre-load
over a 120 s period, to enforce boundary lubrication conditions as
per Neu et al. (2010) [44].
Collagen type I is expressed by surface chondrocytes in foetal
and neonatal articular cartilage. As joints mature, gene expression
and protein levels of collagen type I decline and it is progressively
replaced by collagen type II [54]. In the metacarpophangeal joint of
bovine steers we observed a contraction in the depth of antibody
labelling for collagen type I from the surface, correlating with
maturation of the joint surface from calf to young adult. This
contraction of labelling was not observed in growth factor-treated
cartilage explants. When collagen type I gene expression was
quantitatively assayed, whilst there was as predicted a decrease in
expression in native cartilage in the transition to maturity, we
observed an approximate 6-fold increase in gene synthesis
compared to control untreated cartilage. The function of collagen
type I in surface articular cartilage during postnatal development
has not been deﬁned; the presence of collagen type I ﬁbrils on the
surface cartilage may confer greater resistance to shear stresses
and/or may act as a template for, or initiator of, collagen type II
quaternary structure formation. In this particular instance,
increased collagen type I expression is a biomarker symbolising
that growth factor-treated articular cartilage is still within
a dynamic phase of maturation.
Data from studies examining neo-natal joint development
have noted that anisotropy e a fundamental marker of tissue
maturatione is initiated from the surface zone of articular cartilage[55,56]. We have also noted anisotropy of collagen ﬁbril orientation
in surface chondrocytes of growth factor-treated explants.
However, the classical ‘arcade-like’ orientation of collagen ﬁbrils is
not present in growth factor-treated cartilages. Our studies were
conducted in free swelling condition and in the absence of dynamic
loading, and therefore, even though the cardinal biochemical
and biophysical properties indicate attainment of the mature
cartilage state, clearly this process in incomplete. Biochemical and
biophysical heterogeneity are induced in vivo through adaption to
dynamic loading, and this force is probably required ultimately to
condition articular cartilage, and orientate collagen ﬁbrils at the
macroscale, so that it can attain equilibrium with its immediate
environment.
5. Conclusion
We have quantitatively demonstrated that in vitro growth
factor-induced maturation of immature articular cartilage causes
the appearance of biomechanical and biophysical properties char-
acteristic of mature adult cartilage. This process is rapid, dynamic
and begins at the surface zone of articular cartilage. It is acknowl-
edged that many cartilage repair procedures using cell and
biomaterial constructs produce cartilage that is immature in
phenotype and therefore deﬁcient in many respects to restore
normal, long-lasting, joint function. We hypothesise that the
combined application of FGF2 and TGFb1 to induce maturation of
chondrocytes and/or synthetic constructs, in vitro or in vivo, should
enable this fundamental stumbling block in cartilage repair to be
overcome.
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